Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Johns Hopkins researchers uncover genes at fault for cystic fibrosis-related intestinal obstruction

24.04.2012
Researchers at Johns Hopkins have identified a gene that modifies the risk of newborns with cystic fibrosis (CF) developing neonatal intestinal obstruction, a potentially lethal complication of CF.

Their findings, which appeared online March 15 in PLoS Genetics, along with the findings of their Toronto-based colleagues, published April 1 in Nature Genetics, may lead to a better understanding of how the intestines work and pave the way for identifying genes involved in secondary complications of other disorders.

Soon after birth, most babies excrete their first stool, a tar-like substance called meconium. But not babies with neonatal intestinal obstruction, or meconium ileus (MI), which affects 15 percent of newborns with CF and, rarely, newborns without CF. Their stool is different.

"It is abnormally viscous due to high protein content and low levels of hydration, and the child can't move it through the intestine," says Garry Cutting, M.D., professor of pediatrics at the Johns Hopkins McKusick-Nathans Institute of Genetic Medicine.

The condition results in death if not treated by surgery or enema. But why some newborns with CF get it and others don't is not well understood. To better understand why this is so and to develop models for finding so-called modifier genes—genes that modify the effects of other genes—Cutting and his colleagues aimed to figure out which modifier genes contribute to the development of MI. (From their previous work, they already knew that modifier genes contribute to its development.)

Working with Toronto-based collaborators, members of Cutting's team looked for gene variants that occur in CF patients with MI. They knew that CF is caused by disruption of the CFTR gene, which encodes for a cell membrane protein, so they thought that maybe the genes that alter CFTR's activity and cause MI might also encode for cell membrane proteins; after all, a cell membrane protein is more likely to interact with a nearby cell membrane protein than with a protein that's deep inside the cell. They tested DNA samples from 3,763 CF patients—611 who had had MI and 3152 who hadn't—to compare genes that encode for cell membrane proteins to those that encode for unrelated proteins. Three of the 155 genes tested that encode for cell membrane proteins correlated with risk for MI, compared with none of the 231 genes tested that encode for unrelated proteins.

"These genes have common variants that all of us happen to be carrying around," says Cutting, "and just by chance, if you have a child with CF, these common variants play a role in modifying risk for meconium ileus." The researchers wanted to look for additional gene variants associated with an increased risk for MI, using a different approach.

In an earlier study, Cutting's team had found a region of human chromosome 8 to be linked to MI. To pinpoint which gene within that region leads to the condition, the researchers analyzed the DNA of 133 families with at least two CF children, at least one of whom previously had MI. The DNA was tested to determine which parts of chromosome 8 parents had passed down to their children who had MI.

Using this approach, the researchers found variants of the methionine sulfoxide reductase (MSRA) gene—in this case, a particular combination of DNA alterations close to and within the gene—that appeared significantly more often in children who had MI. In an unrelated CF patient population from Canada, they found evidence of the same link between MSRA and MI, which helped confirm their results.

While the researchers now knew that CF patients with a certain MSRA gene variant tended to have had MI as newborns, they didn't yet know whether MSRA actually plays a role in MI and hence whether it is truly a modifier gene. To address this question, they turned to mice engineered to have CF that tend to die from intestinal obstruction and developed three genetically modified versions of these mice: one with both MSRA genes intact, one with only one intact, and one with none intact. The fewer the copies of intact MSRA genes, the more likely the mice were to survive. In other words, the loss of MSRA protected the mice from fatal intestinal obstruction.

Cutting and his colleagues don't know how exactly the loss of MSRA reduces risk for fatal intestinal obstruction, but they suspect that MSRA's ability to alter the activity of specific intestinal enzymes may be the key. They suspect that with reduced levels of MSRA, the enzymes are free to do their job breaking down proteins that make up meconium so that meconium can pass through the intestines and be evacuated normally at birth.

The researchers' work on MSRA could shed light on how meconium normally gets broken down in the intestines. Moreover, use of the techniques pioneered by Cutting and his colleagues may lead to identification of modifier genes that play roles in other complications of CF, like lung function, and in other diseases caused by a single gene, like Huntington's disease.

The studies were funded by the National Institutes of Health (NHLBI and NIDDK) and the Cystic Fibrosis Foundation.

Authors on the PLoS Genetics paper are: Lindsay B. Henderson, Vishal K. Doshi, Scott M. Blackman, Kathleen M. Naughton, and Garry R. Cutting of Johns Hopkins; Rhonda G. Pace and Michael R. Knowles of University of North Carolina at Chapel Hill; Jackob Moskovitz of University of Kansas, Lawrence; Peter R. Durie of Hospital for Sick Children, Toronto, Ontario, Canada; and Mitchell L. Drumm of Case Western Reserve University.

Authors on the Nature Genetics paper are: Lei Sun, Johanna Rommens, Weili Li, Peter R Durie, Lisa Strug of University of Toronto, Toronto, Ontario, Canada; Harriet Corvol, Annick Clement and Pierre-Yves Boëlle of Pierre et Marie Curie University, Paris, France ; Xin Li, Theodore Chiang, Fan Lin, Ruslan Dorfman, Rashmi V Parekh, Mary Corey, Julian Zielenski of the Hospital for Sick Children, Toronto, Ontario, Canada; Pierre-François Busson of St Antoine Hospital, Paris, France; Diana Zelenika of Centre National de Génotypage, Evry, France ; Scott Blackman, Vishal Doshi, Lindsay Henderson, Kathleen Naughton and Garry R Cutting of Johns Hopkins; Wanda K O'Neal, Rhonda G Pace, Jaclyn R Stonebraker, Sally D Wood and Fred A Wright, and Michael R. Knowles of University of North Carolina at Chapel Hill; and Mitchell L. Drumm of Case Western Reserve University.

On the Web:
http://www.hopkinsmedicine.org/geneticmedicine/
http://www.hopkinsmedicine.org/geneticmedicine/People/Faculty/cutting.html
http://www.plosgenetics.org/home.action
http://www.nature.com/ng/index.html

Audrey Huang | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>